Readout Capital, LP - 19 Mar 2025 SCHEDULE 13G Report for PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share (DTIL)

Filing Manager
Readout Capital, LP
Reporting Manager
Matthew Smith
Security
PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share
Symbol
DTIL
Shares outstanding
10,481,730 shares
Disclosed Ownership
932,874 shares
Ownership
8.9%
Form type
SCHEDULE 13G
Filing time
26 Mar 2025, 18:09:57 UTC
Date of event
19 Mar 2025
Next filing
14 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Readout Capital, LP disclosed 8.9% ownership in PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share (DTIL) on 19 Mar 2025."

Quick Takeaways

  • Readout Capital, LP filed SCHEDULE 13G for PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share (DTIL).
  • Disclosed ownership: 8.9%.
  • Date of event: 19 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 26 Mar 2025, 18:09.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Readout Capital, LP 8.8% 920,000 200,000 720,000 /s/ Matthew Smith Matthew Smith/Manager, Readout Capital GP, LLC, its General Partner
Readout Capital GP, LLC 8.8% 920,000 200,000 720,000 /s/ Matthew Smith Matthew Smith/Manager
ROC Holdings SPV II, LP 6.9% 720,000 0 720,000 /s/ Matthew Smith Matthew Smith/Manager, Readout Holdings GP, LLC, its General Partner
Readout Holdings GP, LLC 6.9% 720,000 0 720,000 /s/ Matthew Smith Matthew Smith/Manager
Matthew Smith 8.9% 932,874 212,874 720,000 /s/ Matthew Smith Matthew Smith/Self

Sponsored